Literature DB >> 26181013

EGFR Mutations in Non-Small-Cell Lung Cancer: Find, Divide, and Conquer.

Daniel Morgensztern1, Katerina Politi2, Roy S Herbst2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181013     DOI： 10.1001/jamaoncol.2014.278

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  10 in total

1.  Pragmatic approaches to address expansion cohort design.

Authors:  Suzanne E Dahlberg; Robert J Gray
Journal:  Cancer       Date:  2018-07-05       Impact factor: 6.860

2.  Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting Del19/T790M/C797S Mutation.

Authors:  Hualin Zhang; Ruliang Xie; Hawaa Ai-Furas; Yupeng Li; Qingxia Wu; Jian Li; Fang Xu; Tianfeng Xu
Journal:  ACS Med Chem Lett       Date:  2022-01-14       Impact factor: 4.345

Review 3.  The pharmacogenomics of drug resistance to protein kinase inhibitors.

Authors:  Nancy K Gillis; Howard L McLeod
Journal:  Drug Resist Updat       Date:  2016-07-05       Impact factor: 18.500

4.  In vitro biomechanical properties, fluorescence imaging, surface-enhanced Raman spectroscopy, and photothermal therapy evaluation of luminescent functionalized CaMoO4:Eu@Au hybrid nanorods on human lung adenocarcinoma epithelial cells.

Authors:  Qifei Li; Abdul K Parchur; Anhong Zhou
Journal:  Sci Technol Adv Mater       Date:  2016-07-26       Impact factor: 8.090

5.  Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities.

Authors:  Elena Fountzilas; Sofia Levva; Giannis Mountzios; Genovefa Polychronidou; Nikos Maniadakis; Vassiliki Kotoula; George Fountzilas
Journal:  J Glob Oncol       Date:  2018-09

6.  Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study.

Authors:  Yu-Hung Fang; Yao-Hsu Yang; Meng-Jer Hsieh; Ming-Szu Hung; Yu-Ching Lin
Journal:  Cancer Manag Res       Date:  2019-09-19       Impact factor: 3.989

7.  CusVarDB: A tool for building customized sample-specific variant protein database from next-generation sequencing datasets.

Authors:  Sandeep Kasaragod; Varshasnata Mohanty; Ankur Tyagi; Santosh Kumar Behera; Arun H Patil; Sneha M Pinto; T S Keshava Prasad; Prashant Kumar Modi; Harsha Gowda
Journal:  F1000Res       Date:  2020-05-11

8.  A dynamic model of CT scans for quantifying doubling time of ground glass opacities using histogram analysis.

Authors:  József Z Farkas; Gary T Smith; Glenn F Webb
Journal:  Math Biosci Eng       Date:  2018-10-01       Impact factor: 2.080

9.  The paradoxical functions of EGFR during breast cancer progression.

Authors:  Remah Ali; Michael K Wendt
Journal:  Signal Transduct Target Ther       Date:  2017-01-20

10.  Destabilizing single chain major histocompatibility complex class I protein for repurposed enterokinase proteolysis.

Authors:  Jackwee Lim
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.